Indications and uses
• relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
• relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
• adults and children 12 years and over: • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. 10 mg: • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn 20 mg: • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking b...
Famotidine USP 10 mg and 20 mg
Acid reducer
• relieves heartburn associated with acid indigestion and sour stomach
• prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
Allergy alert:Do not use if you are allergic to famotidine or other acid reducers
• if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
• with other acid reducers
• had heartburn over 3 months. This may be a sign of a more serious condition.
• heartburn with
lightheadedness, sweating, or dizziness
• chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
• frequent
chest pain
• frequent wheezing, particularly with heartburn
• unexplained weight loss
• nausea or vomiting
• stomach pain
• kidney disease
taking a prescription drug. Acid reducers may interact with certain prescription drugs.
• your heartburn continues or worsens
• you need to take this product for more than 14 days
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
• adults and children 12 years and over:
• to
relievesymptoms, swallow 1 tablet with a glass of water. Do not chew.
10 mg:
• to
preventsymptoms, swallow 1 tablet with a glass of water at any time from
15 to 60 minutes beforeeating food or drinking beverages that cause heartburn
20 mg:
• to preventsymptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes beforeeating food or drinking beverages that cause heartburn
• do not use more than 2 tablets in 24 hours
• children under 12 years: ask a doctor
• read the directions and warnings before use
• keep the carton. It contains important information.
• store at 20° to 25°C (68° to 77°F)
• protect from moisture
10 mg:
carnauba wax, corn starch, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, talc, titanium dioxide.
20 mg:
carnauba wax, corn starch, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, talc, titanium dioxide, red iron oxide and yellow iron oxide.
1-888-375-3784
JUST ONE TABLET prevents and relieves heartburn due to acid indigestion brought on by eating and drinking certain foods and beverages.
Tips for Managing Heartburn
· Do not lie flat or bend over after eating
· Do not wear tight-fitting clothing around the stomach
· Do not eat before bedtime
· Raise the head of your bed
· Avoid heartburn-causing foods such as rich, spicy, fatty or fried foods, chocolate, caffeine, alcohol, and certain fruits and vegetables
· Eat slowly and avoid big meals
· If overweight, lose weight
· Quit smoking
Distributed by CDMA, Inc.
Novi, MI 48375
www.qualitychoice.com
Questions: 800-935-2362
Famotidine Tablets USP 10 mg - 30s container label

Famotidine Tablets USP 10 mg - 30s container carton label

Famotidine Tablets USP 20 mg - 50s container label

Famotidine Tablets USP 20 mg - 50s container carton label

| Class | Version | Type | Effective |
|---|---|---|---|
| FAMOTIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83324-003-30 | famotidine | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 | |
| 83324-003-30 | famotidine | 30 in 1 CONTAINER | TABLET, FILM COATED | 30 | 1 | |
| 83324-008-50 | famotidine | 50 in 1 CONTAINER | TABLET, FILM COATED | 50 | 1 | |
| 83324-008-50 | famotidine | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83324-003 | FAMOTIDINE (FAMOTIDINE) TABLET, FILM COATED [CHAIN DRUG MARKETING ASSOCIATION, INC.] | 1 | Current NDC, 2 package rows | 20240328_6daf1ebe-b0a2-4413-bf25-3de6eb64b0c6.zip |
| 83324-008 | FAMOTIDINE (FAMOTIDINE) TABLET, FILM COATED [CHAIN DRUG MARKETING ASSOCIATION, INC.] | 1 | Current NDC, 2 package rows | 20240328_6daf1ebe-b0a2-4413-bf25-3de6eb64b0c6.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83324-003 | 83324-003-30 |
| 83324-008 | 83324-008-50 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215766-001 | FAMOTIDINE | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | ||
| A215766-002 | FAMOTIDINE | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A215766-001 | FAMOTIDINE | 10MG | TABLET / ORAL | 2021-11-08 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A215766-002 | FAMOTIDINE | 20MG | TABLET / ORAL | 2021-11-08 | 4b0b4de00fa7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| famotidine | FAMOTIDINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 6daf1ebe-b0a2-4413-bf25-3de6eb64b0c6 | 2024-03-27 | Warnings | 83324-008-50 83324-003-30 83324-008 83324-003 83324000850 83324000330 14a35301-b682-06ca-e063-6394a90a7bc6 6daf1ebe-b0a2-4413-bf25-3de6eb64b0c6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.